Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease.

Sawada H, Oeda T, Umemura A, Tomita S, Kohsaka M, Park K, Yamamoto K, Sugiyama H.

PLoS One. 2015 Jul 28;10(7):e0134118. doi: 10.1371/journal.pone.0134118. eCollection 2015.

2.

[A case of refractory generalized myasthenia gravis with anti-acetylcholine receptor antibodies treated with rituximab].

Hayashi R, Tahara M, Oeda T, Konishi T, Sawada H.

Rinsho Shinkeigaku. 2015;55(4):227-32. doi: 10.5692/clinicalneurol.55.227. Japanese.

PMID:
25904250
3.

Delirium and high fever are associated with subacute motor deterioration in Parkinson disease: a nested case-control study.

Umemura A, Oeda T, Tomita S, Hayashi R, Kohsaka M, Park K, Sugiyama H, Sawada H.

PLoS One. 2014 Jun 2;9(6):e94944. doi: 10.1371/journal.pone.0094944. eCollection 2014.

4.

Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study.

Sawada H, Oeda T, Umemura A, Tomita S, Hayashi R, Kohsaka M, Yamamoto K, Sudoh S, Sugiyama H.

PLoS One. 2014 Jan 31;9(1):e85886. doi: 10.1371/journal.pone.0085886. eCollection 2014.

5.

Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study.

Sawada H, Oeda T, Yamamoto K, Umemura A, Tomita S, Hayashi R, Kohsaka M, Kawamura T.

BMC Neurol. 2013 Oct 12;13:145. doi: 10.1186/1471-2377-13-145.

6.

Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson's disease (EDAP).

Sawada H, Oeda T.

BMJ Open. 2013 Sep 25;3(9):e003533. doi: 10.1136/bmjopen-2013-003533.

7.

Clinical factors associated with abnormal postures in Parkinson's disease.

Oeda T, Umemura A, Tomita S, Hayashi R, Kohsaka M, Sawada H.

PLoS One. 2013 Sep 19;8(9):e73547. doi: 10.1371/journal.pone.0073547. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/d5228e50-2098-44c9-b663-829dd9b4b97e.

8.

Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.

Umemura A, Oeda T, Hayashi R, Tomita S, Kohsaka M, Yamamoto K, Sawada H.

PLoS One. 2013 Apr 17;8(4):e61066. doi: 10.1371/journal.pone.0061066. Print 2013.

9.

Lack of association between BST1 polymorphisms and sporadic Parkinson's disease in a Japanese population.

Miyake Y, Tanaka K, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group.

J Neurol Sci. 2012 Dec 15;323(1-2):162-6. doi: 10.1016/j.jns.2012.09.008. Epub 2012 Sep 29.

PMID:
23026536
10.

MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan.

Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group.

Drug Metab Pharmacokinet. 2013;28(2):138-43. Epub 2012 Sep 11.

11.

UCHL1 S18Y variant is a risk factor for Parkinson's disease in Japan.

Miyake Y, Tanaka K, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson’s Disease Study Group.

BMC Neurol. 2012 Jul 28;12:62. doi: 10.1186/1471-2377-12-62.

12.

SNCA polymorphisms, smoking, and sporadic Parkinson's disease in Japanese.

Miyake Y, Tanaka K, Fukushima W, Kiyohara C, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group.

Parkinsonism Relat Disord. 2012 Jun;18(5):557-61. doi: 10.1016/j.parkreldis.2012.02.016. Epub 2012 Mar 17.

PMID:
22425546
13.

Prostatic stromal tumor of uncertain malignant potential (STUMP) with unrecognized growth pattern.

Fushimi S, Ogino T, Aoki K, Itakura J, Ito T, Oeda T, Yanai H, Matsukawa A.

Pathol Int. 2012 Jan;62(1):69-71. doi: 10.1111/j.1440-1827.2011.02741.x. No abstract available.

PMID:
22192808
14.

Dietary patterns and risk of Parkinson's disease: a case-control study in Japan.

Okubo H, Miyake Y, Sasaki S, Murakami K, Tanaka K, Fukushima W, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson’s Disease Study Group.

Eur J Neurol. 2012 May;19(5):681-8. doi: 10.1111/j.1468-1331.2011.03600.x. Epub 2011 Dec 5.

PMID:
22136555
15.

Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.

Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group.

BMC Neurol. 2011 Jul 25;11:89. doi: 10.1186/1471-2377-11-89.

16.

Occupational risk factors for Parkinson's disease: a case-control study in Japan.

Tanaka K, Miyake Y, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group.

BMC Neurol. 2011 Jul 7;11:83. doi: 10.1186/1471-2377-11-83.

17.

Dietary intake of metals and risk of Parkinson's disease: a case-control study in Japan.

Miyake Y, Tanaka K, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group.

J Neurol Sci. 2011 Jul 15;306(1-2):98-102. doi: 10.1016/j.jns.2011.03.035. Epub 2011 Apr 16.

PMID:
21497832
18.

Intake of Japanese and Chinese teas reduces risk of Parkinson's disease.

Tanaka K, Miyake Y, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group.

Parkinsonism Relat Disord. 2011 Jul;17(6):446-50. doi: 10.1016/j.parkreldis.2011.02.016. Epub 2011 Apr 1.

PMID:
21458354
19.

APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population.

Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson’s Disease Study Group.

J Neural Transm. 2011 Sep;118(9):1335-44. doi: 10.1007/s00702-011-0612-y. Epub 2011 Mar 1.

PMID:
21360299
20.

Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial.

Sawada H, Oeda T, Kuno S, Nomoto M, Yamamoto K, Yamamoto M, Hisanaga K, Kawamura T; Amantadine Study Group.

PLoS One. 2010 Dec 31;5(12):e15298. doi: 10.1371/journal.pone.0015298.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk